Vivosim Lab Inc (VIVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,617 | -6,323 | -26,635 | -19,652 | -13,253 |
| Depreciation Amortization | 379 | 205 | 980 | 824 | 570 |
| Accounts receivable | -116 | -35 | 380 | 336 | 408 |
| Accounts payable and accrued liabilities | -476 | -75 | 164 | 183 | -15 |
| Other Working Capital | -1,437 | -1,036 | 24 | -444 | -1,214 |
| Other Operating Activity | 3,177 | 1,329 | 4,712 | 3,455 | 2,158 |
| Operating Cash Flow | $-11,090 | $-5,935 | $-20,375 | $-15,298 | $-11,346 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 27 | 1 | -76 | -34 | -9 |
| Investing Cash Flow | $27 | $1 | $-76 | $-34 | $-9 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,996 | 4,996 | 13,377 | 6,966 | 5,129 |
| Other Financing Activity | -60 | -52 | -223 | -136 | -145 |
| Financing Cash Flow | $4,936 | $4,944 | $13,154 | $6,830 | $4,984 |
| Beginning Cash Position | 36,556 | 36,556 | 43,853 | 43,853 | 43,853 |
| End Cash Position | 30,429 | 35,566 | 36,556 | 35,351 | 37,482 |
| Net Cash Flow | $-6,127 | $-990 | $-7,297 | $-8,502 | $-6,371 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,090 | -5,935 | -20,375 | -15,298 | -11,346 |
| Capital Expenditure | N/A | N/A | -79 | -37 | -11 |
| Free Cash Flow | -11,090 | -5,935 | -20,454 | -15,335 | -11,357 |